← Browse by Condition
Medical Condition

indolent systemic mastocytosis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04655118 Phase 2
Recruiting

Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

Enrollment
121 pts
Location
United States, Austr...
Sponsor
Telios Pharma, Inc.
View Trial →